Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001062993-23-013930

Chief Financial Officer sold 134,961 shares at $8.14 ($1,098,583)

  • Chief Financial Officer acquired 134,961 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

PETERSON TYCHO · Chief Financial Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2023-06-20 Exercise or conversion : show line 1 in the form 10b5-1 +134,961 $7.30 $985,215 534,180 D
2023-06-20 Sale : show line 2 in the form 10b5-1 −70,000 $8.14 $569,800 464,180 D
2023-06-20 Sale : show line 3 in the form 10b5-1 −64,961 $8.14 $528,783 399,219 D
Open-market sales · 134,961 sh · avg $8.14 · $1,098,583

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-06-20 Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (right to buy) −134,961 447,868 D
Loading xslF345X04/form4.xml…